Categories: News

Cerner to Release Fourth Quarter 2020 Earnings Results February 10

KANSAS CITY, Mo., Jan. 11, 2021 (GLOBE NEWSWIRE) — Cerner Corporation (Nasdaq: CERN) today announced it will release its fourth quarter 2020 earnings results after the market closes Wednesday, February 10th. Following the release, the company will hold a conference call at 3:30 p.m. CT that can be accessed via dial-in or webcast. On the call, Cerner will discuss its results and outlook and answer questions from the investment community. The call may also include discussion of Cerner developments and other material and forward-looking information about business and financial matters.

The dial-in number for the conference call is (678) 509-7542; the passcode is Cerner. The company recommends joining the call 15 minutes early for registration. An audio webcast will be available live and archived on Cerner’s website in the Investor Relations section.

About Cerner
Cerner’s health technologies connect people and information systems at thousands of contracted provider facilities worldwide dedicated to creating smarter and better care for individuals and communities. Recognized globally for innovation, Cerner assists clinicians in making care decisions and assists organizations in managing the health of their populations. The company also offers an integrated clinical and financial system to help manage day-to-day revenue functions, as well as a wide range of services to support clinical, financial and operational needs, focused on people. For more information, visit Cerner.com, The Cerner Blog, The Cerner Podcast or connect on Facebook, Instagram, LinkedIn or Twitter. Nasdaq: CERN. Health care is too important to stay the same.

Media Contact: Stephanie Greenwood, Public Relations, (816) 201-2137
Investor Contact: Allan Kells, Investor Relations, (816) 201-2445

Staff

Recent Posts

RAAPID Raises Series A from M12, Microsoft’s Venture Fund to Scale Next-Generation Healthcare Risk Adjustment

Company reports 300% revenue growth in 2024 and advances partnerships with nation's leading health systems…

57 minutes ago

Anatomage Announces Acquisition of Cloud-based Software Company BioDigital

SANTA CLARA, Calif., Jan. 10, 2025 /PRNewswire/ -- Anatomage Inc., a leader in medical education…

57 minutes ago

Avantor® to Report Fourth Quarter and Full Year 2024 Earnings on Friday, February 7, 2025

RADNOR, Pa., Jan. 10, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider…

57 minutes ago

Cmbio® Acquires Eagle Genomics’ Assets to Enhance Multi-Omics Software and AI/ML capabilities of its Digital Biology Platform.

COPENHAGEN, Denmark, Jan. 10, 2025 /PRNewswire/ -- Cmbio®, a global leader in multi-omics science and…

57 minutes ago

The New York Stem Cell Foundation Research Institute Enters Agreement to Accelerate Precision Drug Discovery for Neurodegenerative Disease

Partnership Will Harness NYSCF's Automated Cell Culture Systems and Artificial Intelligence Capabilities to Study Disease at…

57 minutes ago

Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine

MINNEAPOLIS, Jan. 10, 2025 /PRNewswire/ -- Bio-Techne (NASDAQ: TECH), a global leader in life science…

57 minutes ago